Unique features of high-density lipoproteins in the Japanese: in population and in genetic factors
- PMID: 25849946
- PMCID: PMC4425149
- DOI: 10.3390/nu7042359
Unique features of high-density lipoproteins in the Japanese: in population and in genetic factors
Abstract
Despite its gradual increase in the past several decades, the prevalence of atherosclerotic vascular disease is low in Japan. This is largely attributed to difference in lifestyle, especially food and dietary habits, and it may be reflected in certain clinical parameters. Plasma high-density lipoprotein (HDL) levels, a strong counter risk for atherosclerosis, are indeed high among the Japanese. Accordingly, lower HDL seems to contribute more to the development of coronary heart disease (CHD) than an increase in non-HDL lipoproteins at a population level in Japan. Interestingly, average HDL levels in Japan have increased further in the past two decades, and are markedly higher than in Western populations. The reasons and consequences for public health of this increase are still unknown. Simulation for the efficacy of raising HDL cholesterol predicts a decrease in CHD of 70% in Japan, greater than the extent by reducing low-density lipoprotein cholesterol predicted by simulation or achieved in a statin trial. On the other hand, a substantial portion of hyperalphalipoproteinemic population in Japan is accounted for by genetic deficiency of cholesteryl ester transfer protein (CETP), which is also commonly unique in East Asian populations. It is still controversial whether CETP mutations are antiatherogenic. Hepatic Schistosomiasis is proposed as a potential screening factor for historic accumulation of CETP deficiency in East Asia.
Figures









Similar articles
-
Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1068-1075. doi: 10.1161/ATVBAHA.117.309114. Epub 2017 Apr 20. Arterioscler Thromb Vasc Biol. 2017. PMID: 28428219 Free PMC article.
-
Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1148-54. doi: 10.1161/01.atv.0000024566.57589.2e. Arterioscler Thromb Vasc Biol. 2002. PMID: 12117730 Clinical Trial.
-
Long-term Benefits and Harms Associated With Genetic Cholesteryl Ester Transfer Protein Deficiency in the General Population.JAMA Cardiol. 2022 Jan 1;7(1):55-64. doi: 10.1001/jamacardio.2021.3728. JAMA Cardiol. 2022. PMID: 34613338 Free PMC article.
-
Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors.Mol Cells. 2014 Nov;37(11):777-84. doi: 10.14348/molcells.2014.0265. Epub 2014 Nov 6. Mol Cells. 2014. PMID: 25410905 Free PMC article. Review.
-
Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis.Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):160-7. doi: 10.1161/01.atv.0000054658.91146.64. Arterioscler Thromb Vasc Biol. 2003. PMID: 12588754 Review.
Cited by
-
Continuous and Marked Increase of Japanese HDL Associates Paradoxically with their Nutritional Shift.J Atheroscler Thromb. 2023 Aug 1;30(8):919-933. doi: 10.5551/jat.63894. Epub 2022 Nov 15. J Atheroscler Thromb. 2023. PMID: 36384911 Free PMC article.
-
Determinants and correlates of adipose tissue insulin resistance index in Japanese women without diabetes and obesity.BMJ Open Diabetes Res Care. 2020 Sep;8(1):e001686. doi: 10.1136/bmjdrc-2020-001686. BMJ Open Diabetes Res Care. 2020. PMID: 32900700 Free PMC article.
-
Different Associations of Plasma Biomarkers in Alzheimer's Disease, Mild Cognitive Impairment, Vascular Dementia, and Ischemic Stroke.J Clin Neurol. 2018 Jan;14(1):29-34. doi: 10.3988/jcn.2018.14.1.29. J Clin Neurol. 2018. PMID: 29629537 Free PMC article.
-
Effect of CSL112 (apolipoprotein A-I [human]) on cholesterol efflux capacity in Japanese subjects: Findings from a phase I study and a cross-study comparison.Clin Transl Sci. 2022 Oct;15(10):2331-2341. doi: 10.1111/cts.13361. Epub 2022 Aug 7. Clin Transl Sci. 2022. PMID: 35933730 Free PMC article. Clinical Trial.
-
HDL and atherosclerotic cardiovascular disease: genetic insights into complex biology.Nat Rev Cardiol. 2018 Jan;15(1):9-19. doi: 10.1038/nrcardio.2017.115. Epub 2017 Aug 10. Nat Rev Cardiol. 2018. PMID: 28795686 Review.
References
-
- Ministry of Health, Labor and Welfare of Japan, National Health and Nutritional Survey. [(accessed on 1 January 2012)]. Available online: http://www.mhlw.go.jp/toukei/itiran/gaiyo/k-eisei.html. (In Japanese)
-
- Worth R.M., Kato H., Rhoads G.G., Kagan K., Syme S.L. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: Mortality. Amer. J. Epidemiol. 1975;102:481–490. - PubMed
-
- Sekikawa A., Curb J.D., Ueshima H., El-Saed A., Kadowaki T., Abbott R.D., Evans R.W., Rodriguez B.L., Okamura T., Sutton-Tyrrell K., et al. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: A cross-sectional study. J. Am. Coll. Cardiol. 2008;52:417–424. doi: 10.1016/j.jacc.2008.03.047. - DOI - PMC - PubMed
-
- Sasai K., Okuyama-Noji K., Hibino T., Ikeuchi R., Sakuma N., Fujinami T., Yokoyama S. Human cholesteryl ester transfer protein (CETP) measured by enzyme-linked immunosorbent assay with two monoclonal antibodies against rabbit cetp: Plasma CETP and lipoproteins among Japanese hypercholesterolemic patients. Clin. Chem. 1998;44:1466–1473. - PubMed
-
- Goto A., Sasai K., Suzuki S., Fukutomi T., Ito S., Matsushita T., Okamoto M., Suzuki T., Itoh M., Okuyama-Noji K., et al. Cholesteryl ester transfer protein and atherosclerosis in Japanese subjects: A study based on coronary angiography. Atheroscelrosis. 2001;159:153–163. doi: 10.1016/S0021-9150(01)00476-2. - DOI - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous